ConferenceSeries Ltd is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing eighth “World Congress on Pharmacology and Toxicology” (Pharmacology Congress 2017) scheduled to be held during July 24-26, 2017 at Melbourne, Australia. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmacology and Toxicology.
ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Pharmacology Congress 2017 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacology one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat accordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs.
Why to attend???
Join your peers around the world focused on learning about Pharmacology, toxicology and related advances, which is your single best opportunity to reach the largest assemblage of participants from the Pharmacology and toxicology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name and recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Pharmacology are hallmarks of this conference.
Target Audience:
Students, Scientists, Researchers, and Faculty of Pharmaceutical Universities
Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
Business Entrepreneurs, Training Institutes, Software developing companies
Manufacturing Medical Devices Companies, CRO and Data Management Companies.
2017 Highlights:
300+ Participation (70 Industry: 30 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
20+ Exhibitors
14 Innovative Educational Sessions
5+ Workshops
B2B Meetings
Track 1:Pharmacology
Track 1-1Scope
Track 1-2Medicine development and safety testing
Track 1-3Drug legislation and safety
Track 1-4Reverse pharmacology
Track 2:Toxicology
Track 2-1Emergent Contaminants
Track 2-2Regulatory toxicology
Track 2-3Analytical toxicology
Track 2-4Toxicokinetics
Track 2-5Toxicologic Pathology
Track 2-6Plant toxicology
Track 3:Clinical Pharmacology & Receptor Therapy
Track 3-1Drug interactions and pharmacological compatibilities
Track 3-2Receptor theory for drug effects
Track 3-3Clinical efficacy and safety evaluation
Track 3-4Novel options for the pharmacological treatment of chronic diseases
Track 4:Pharmacokinetics and Pharmacodynamics
Track 4-1Pharmacokinetic models
Track 4-2Bioavailability
Track 4-3Clinical pharmacokinetics
Track 4-4Population pharmacokinetics
Track 4-5Multicellular pharmacodynamics
Track 4-6Toxicodynamics
Track 4-7Networked Multicellular Pharmacodynamics
Track 5:Cardiovascular and Ethno pharmacology
Track 5-1Role of drugs in coronary circulation
Track 5-2Heart Diseases and failure
Track 5-3Interventional cardiology
Track 5-4Cardiotoxicity
Track 6:Pharmacogenetics and Pharmacogenomics
Track 6-1Cancer pharmcogenetics
Track 6-2Recent advances in DNA repair
Track 6-3Pharamcogenetic approach involved in modulating cell processes
Track 6-4Mutagenecity- its implications in cancer following chemotherapy
Track 6-5Drug dosing guidelines
Track 6-6Recent advances in variant-disease pairs
Track 6-7Pharmacology of the Vascular endothelium
Track 6-8Pharmacology of drugs affecting vascular tone and blood pressure
Track 6-9Pharmacognosy
Track 7:Drug Screening and Discovery
Track 7-1Reverse pharmacology
Track 7-2Target based drug discovery
Track 7-3Screening of chemical libraries and its pharmacology
Track 7-4Methods To determine biological targeting
Track 7-5Classical pharmacology
Track 8:Food and Chemical Toxicology
Track 8-1Molecular toxicology
Track 8-2Biochemical toxicology
Track 8-3Biotransformation of chemicals
Track 8-4Food and chemical toxicology
Track 8-5Food safety and toxicology
Track 8-6Food and cosmetic toxicology
Track 9:Environmental Toxicology and Human Toxicology
Track 9-1Biological markers
Track 9-2Biomagnification
Track 9-3Acute poisonings in pregnancy
Track 9-4Laboratory diagnosis of poisonings
Track 10:Genotoxicity
Track 10-1Genotoxic Chemotherapy
Track 10-2Bacterial Reverse Mutation Assay
Track 10-3In vitro Toxicology Testing
Track 10-4Comet Assay
Track 11:Neuropharmacology & Psychopharmacology
Track 11-1Neuro signaling and its pathways
Track 11-2Neurogenesis and repair
Track 11-3Neuro Immune pharmacology and its associated diseases
Track 11-4Neurocognitive effects associated with therapeutic drugs
Track 11-5Dose response relation in psychiatric medications
Track 11-6Effect of androgenic anabolic steroids on psychosis
Track 12:Nursing Pharmacology
Track 12-1Regulatory toxicology
Track 12-2Drug interactions and pharmacological compatibilities
Track 12-3Population pharmacokinetics
Track 12-4Drug dosing guidelines
Track 12-5Pharmacology of drugs affecting vascular tone and blood pressure
Track 13:Ethnopharmacology
Track 13-1Latest Trends in Ethnopharmacology
Track 13-2Phytochemical Studies of Plants and Plant Extracts
Track 13-3Advancements in Ayurveda and Unani
Track 13-4Natural Products in Clinical Pharmacology
07月24日
2017
07月26日
2017
摘要截稿日期
注册截止日期
留言